Aileron Therapeutics' Phase 1b trial shows LTI-03 improved biomarkers and reduced SPD levels, indicating the potential to ...

(RTTNews) - Aileron Therapeutics, Inc. (ALRN), Wednesday announced positive topline data from the cohort 2 of Phase 1b study evaluating LTI-03 in patients with idiopathic pulmonary fibrosis (IPF).

Survival rates for idiopathic pulmonary fibrosis are worse than all solid cancers except for lung and pancreatic cancer. | ...

As physicians we take an oath to do no harm, yet are trapped providing care in a system that leaves patients confined and at ...

The UAB Division of Pulmonary, Allergy and Critical Care Medicine is an integral part of one of the nation's largest health systems. Nationally known for our compassionate care, cutting-edge research, ...

With medication, she was able to keep her symptoms from worsening, but a lung transplant was the only... Joe Rands has been living with pulmonary fibrosis for more than 15 years. However breathing ...

Spirometry, a type of pulmonary ... lungs to fully expand. This includes obesity, scoliosis (abnormal curvature of the spine), diaphragmatic paralysis, and pleural effusion. Intra-thoracic restriction ...

What is cystic fibrosis liver disease? Liver disease associated with cystic fibrosis (CF) has been increasingly diagnosed during recent years, most likely due to the combined effect of systematic ...

PULMONARY alveolar microlithiasis ... The head was not examined. On gross examination the heart was not remarkable. The gross appearance of the right lung is shown in Figures 4 and 5.

1 State Key Laboratory Cell Differentiation and Regulation, Henan International Joint Laboratory of Pulmonary ... fibrosis and open new avenues for therapy. Cytoskeletal remodeling impacts fibrosis ...

Emily Pink, 21, has cystic fibrosis, a rare genetic disorder that causes a build-up of sticky mucus in her lungs and digestive system. She remembers a childhood filled with hospital stays brought ...